期刊文献+

慢性肾衰竭终末期高血压40例疗效观察 被引量:3

Clinical Observation on Therapeutic Effect of 40 Cases of End-stage Chronic Renal Function Failure-induced Hypertension
下载PDF
导出
摘要 目的观察透析治疗、降压药物治疗对慢性肾衰竭(CRF)终末期高血压的降压效果。方法收集CRF终末期高血压患者40例,分为透析组(22例)和非透析治疗组(18例)进行治疗并分析其疗效。结果①透析组5例患者经充分透析后血压降至目标值(130/80mmHg),其余17例加用血管紧张素转换酶抑制剂(ACEI)、钙离子通道阻滞剂(CCB)治疗后仍有2例血压难以降至目标值,此时加用利尿剂、β-受体阻滞剂后降至目标值以下。②非透析组均服用CCB,12例患者血压难以降至目标值,加用利尿剂、β-受体阻滞剂后6例降至目标值以下。结论充分透析可有效降压,在此基础上合理联用ACEI、CCB及β-受体阻滞剂,同时纠正钙磷比例失调,控制甲状旁腺功能亢进可增强降压效果。 Objective To observe the therapeutic effect of hemodialysis or hypotensive drugs in the treatment of 40 cases of end-stage chronic renal function failure-induced hypertension. Methods Forty patients with end-stage chronic renal function failure-induced hypertension admitted on our hospital during 2001.1-2007.7 were randomly divided into two groups: hemodialysis group (n=22) and non-hemodialysis group (n=18). The therapeutic effectiveness was analyzed. Results In hemodialysis group, blood pressure was reduced to the target value (130/80 mmHg)in 5 cases after sufficient hemodialysis. And in the remaining 17 cases, blood pressure of 15 cases reached the target value after combined use of angiotensin converting enzyme inhibitor (ACEI), calcium channel blocker (CCB), and that of 2 cases reached the target value after combined use of ACEI, CCB, diuretic agent, β-receptor blocker, etc. In non-hemodialysis group, all patients were administered with calcium channel blocker, but blood pressure of 12 cases did not reach the target value. After combined use of diuretic agent, β-receptor blocker, etc, blood pressure of 6 cases was reduced to below the target value.Conclusion Sufficient hemodialysis can lower blood pressure effectively. Combined use of ACEI, calcium channel blocker and β-receptor blocker, and correcting the imbalance between calcium and phosphonium and controlling hyperparathyroidism can reach the satisfactory therapeutic effects in lowering blood pressure.
作者 陈向前
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2008年第4期526-528,共3页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 慢性肾衰竭 高血压 治疗效果 renal failure, chronic, hypertension, treatment effectiveness
  • 相关文献

参考文献5

  • 1KLAHR S. The kidney in hypertension-villain and victim[J]. N EnglJ Med, 1989,320(11):731-733.
  • 2付荣国,王莉,郭蕊军,张红利,赵莉,郭芳丽.在线血液透析滤过对终末期肾衰竭高血压患者的治疗作用[J].临床内科杂志,2006,23(5):322-324. 被引量:24
  • 3SLATOPOLSKY E, LOPEZZ-HILKER S, DELMEZ J, et al. The interrelationship between vitamin D and parathyroid hor mone secretion in health and disease[M]//Davison A M. Nephrology. Cambridge: Cambridge University Press, 1988 1067-1075.
  • 4SPRINGER T A. Adhesion receptors of the immune system[J]. Nature,1990,346(6283) :425-434.
  • 5STRUTZ F, NEILSON E G. The role of lymphocytes in the progression of interstitial disease [J]. Kidney Int Suppl, 1994, 45(2) :s106-s110.

二级参考文献6

  • 1Duranti E, Inperiali P, Sasdeli M. Is Hypertension a mortality risk factor in dialysis? Kidney Int,2003 ,63 :1462-1467.
  • 2Tozawa M, Iseki K, Iseki C ,et al. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic heamodialysis. Kidney Int ,2002,61:717-726.
  • 3吴国荃主编.慢性肾功能不全及替代治疗.北京:北京出版社,1997.130.
  • 4徐学康.肾实质性高血压.见:钱桐荪主编.肾脏病学.北京:华夏出版社,2001.527.
  • 5Ledebo I. On-line preparation of solutions for dialysis practiceal aspects versus safety and regulation. J Am Soc Nephrol, 2002,13 ( Suppll ) :S78-S83.
  • 6王笑云,陆卫平,赵秀芬.高磷对血管平滑肌细胞骨钙素mRNA表达和钙沉积的影响[J].中华肾脏病杂志,2003,19(2):105-108. 被引量:23

共引文献23

同被引文献30

  • 1黄小妹,张英,张黎民,伊平,汪贤聪,常耀武,高明,唐雅文,李红兵.武汉地区维持性血液透析患者生活质量及影响因素[J].中华肾脏病杂志,2005,21(2):88-89. 被引量:40
  • 2马祖等,郑智华,张涤华,郝元涛,叶任高,娄探奇,毛晓玲,刘岩,刘冠贤,朱起之,张增华,汪华林,傅君舟,余学清.血液透析和腹膜透析患者生存质量的多中心调查[J].中华肾脏病杂志,2004,20(6):400-405. 被引量:87
  • 3岑琼,王君俏,王永芬,高中度.210例维持性血液透析患者的生存质量及其影响因素的调查[J].中华护理杂志,2005,40(3):186-188. 被引量:117
  • 4陈江华.提高血液透析患者长期生存率所面临的挑战[J].中华肾脏病杂志,2006,22(3):133-134. 被引量:80
  • 5Coresh J, Selvin E, Stevens L A, et al. Prevalence of chronic kidney disease in the united states[J]. JAMA,2007,298(17) : 2038-2047.
  • 6Zhang L,Wang F,Wang L,et al. Prevalence of chronic kidney disease in china: a cross-sectional survey[J]. Lancet, 2012, 379(9818) : 815-822.
  • 7Muntner P, Anderson A, Charleston J, et al. Hypertension awareness, treatment, and control in adults with CKD : results from the Chronic Renal Insufficiency Cohort (CRIC)Study[J]. Am J Kidney Dis,2010,55(3):441-451.
  • 8Pickering T G. Isolated diastolic hypertension[J]. J Clin Hy- pertens, 2003,5 (6) : 411-413.
  • 9James P A, Oparil S,Carter B L, et al. 2014 evidence-based guideline for the management of high blood pressure in a- dults: report from the panel members appointed to the Eighth Joint National Committee(JNC8) [J].JAMA, 2014,311 (50): 507-520.
  • 10Soltani Z,Rasheed K,Kapusta D R,et al. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases:is it time for reappraisal?[J]. Curt Hypertens Rep,2013,15(3) :175-181.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部